OLMA Olema Pharmaceuticals

• None no insider bought on the open market
• $24.7M sold by 6 insiders outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. Cyrus Harmon Director
   Sale
   $291K 25,000 shares at $11.65 3.4% of stake
   Traded Jul 23–24 Filed Jul 27
   ↗
3. Shawnte Mitchell Chief Legal Officer
   Sale
   $952K 40,000 shares at $23.79
   Traded Mar 3–4 Filed Mar 5
   ↗
4. Cyrus Harmon Director
   Sale
   $269K 10,000 shares at $26.88 1.4% of stake
   Traded Jan 20 Filed Jan 21
   ↗
5. Cyrus Harmon Director
   Sale
   $102K 3,489 shares at $29.12 0.5% of stake
   Traded Jan 14 Filed Jan 16
   ↗
6. Shane William Charles Kovacs Ch. Operating & Financial Off.
   Sale
   $3M 103,822 shares at $28.70 43% of stake
   Traded Jan 13–15 Filed Jan 15
   ↗
7. David C. Myles Ch. Discov. & Non-clin Dev Off
   Sale
   $3.1M 110,000 shares at $28.25
   Traded Jan 12–14 Filed Jan 14
   ↗
8. Cyrus Harmon Director
   Sale
   $82K 2,881 shares at $28.53 0.4% of stake
   Traded Dec 22, 2025 Filed Dec 29, 2025
   ↗
9. Naseem Zojwalla Chief Medical Officer
   Sale
   $7.5M 269,509 shares at $27.94 98% of stake
   Traded Dec 19–23 Filed Dec 23, 2025
   ↗
10. David C. Myles Ch. Discov. & Non-clin Dev Off
    Sale
    $1.6M 51,000 shares at $30.46 8.5% of stake
    Traded Dec 19, 2025 Filed Dec 23, 2025
    ↗
11. Ian T Clark Director
    Sale
    $7.9M 264,800 shares at $29.73 100% of stake
    Traded Dec 19, 2025 Filed Dec 23, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 option exercises, 5 gifts, and 1 stock grant.